DocGo Inc. Other Noncash Income (Expense)
DocGo Inc. (DCGO) reported Other Noncash Income (Expense) of $123.21 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-08-17
- DocGo Inc. other noncash income (expense) for the quarter ending 2026-06-30 was $123.21K, a 21.94% increase year-over-year.
- DocGo Inc. other noncash income (expense) for the quarter ending 2026-03-31 was $264.96K.
- DocGo Inc. other noncash income (expense) for the quarter ending 2025-12-31 was -$432.78K, a 623.89% decline year-over-year.
- DocGo Inc. other noncash income (expense) for the quarter ending 2025-09-30 was $112.18K.
- DocGo Inc. other noncash income (expense) for fiscal 2025 was -$532.42K, a 332.84% decline from fiscal 2024.
- DocGo Inc. other noncash income (expense) for fiscal 2024 was $228.67K, a 26.98% decline from fiscal 2023.
- DocGo Inc. other noncash income (expense) for fiscal 2023 was $313.13K.
- DocGo Inc. other noncash income (expense) for fiscal 2022 was -$987.48K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 3 month as first filed | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month | Other Noncash Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $123.21K 10-Q · filed 2026-08-17 | $388.18K 10-Q · filed 2026-08-17 | -$44.60K derived: sum of 3 quarters · filed 2026-08-17 | $67.58K derived: sum of 4 quarters · filed 2026-08-17 | ||
| 2026-03-31 | $264.96K 10-Q · filed 2026-05-11 | -$167.81K derived: sum of 2 quarters · filed 2026-05-11 | -$55.63K derived: sum of 3 quarters · filed 2026-05-11 | $45.41K derived: sum of 4 quarters · filed 2026-08-17 | ||
| 2025-12-31 | -$432.78K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$320.60K derived: sum of 2 quarters · filed 2026-03-16 | -$219.55K derived: sum of 3 quarters · filed 2026-08-17 | -$532.42K 10-K · filed 2026-03-16 | ||
| 2025-09-30 | $112.18K 10-Q · filed 2025-11-10 | $213.23K derived: sum of 2 quarters · filed 2026-08-17 | -$99.64K 10-Q · filed 2025-11-10 | -$17.03K derived: sum of 4 quarters · filed 2026-08-17 | ||
| 2025-06-30 | $101.05K 10-Q · filed 2026-08-17 | -$211.82K 10-Q · filed 2026-08-17 | -$129.22K derived: sum of 3 quarters · filed 2026-08-17 | -$565.04K derived: sum of 4 quarters · filed 2026-08-17 | ||
| 2025-03-31 | -$312.87K 10-Q · filed 2026-05-11 | -$230.26K derived: sum of 2 quarters · filed 2026-05-11 | -$666.09K derived: sum of 3 quarters · filed 2026-05-11 | -$328.81K derived: sum of 4 quarters · filed 2026-05-11 | ||
| 2024-12-31 | $82.61K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$353.22K derived: sum of 2 quarters · filed 2026-03-16 | -$15.94K derived: sum of 3 quarters · filed 2026-03-16 | $228.67K 10-K · filed 2026-03-16 | ||
| 2024-09-30 | -$435.82K 10-Q · filed 2025-11-10 | -$98.55K derived: sum of 2 quarters · filed 2025-11-10 | $146.06K 10-Q · filed 2025-11-10 | $121.02K derived: sum of 4 quarters · filed 2026-03-16 | ||
| 2024-06-30 | $337.28K 10-Q · filed 2025-08-07 | $581.88K 10-Q · filed 2025-08-07 | $556.84K derived: sum of 3 quarters · filed 2026-03-16 | $600.20K derived: sum of 4 quarters · filed 2026-03-16 | ||
| 2024-03-31 | $244.61K 10-Q · filed 2025-05-08 | $219.57K derived: sum of 2 quarters · filed 2026-03-16 | $262.92K derived: sum of 3 quarters · filed 2026-03-16 | $342.86K derived: sum of 4 quarters · filed 2026-03-16 | ||
| 2023-12-31 | -$25.04K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $18.31K derived: sum of 2 quarters · filed 2026-03-16 | $98.25K derived: sum of 3 quarters · filed 2026-03-16 | $313.13K 10-K · filed 2026-03-16 | ||
| 2023-09-30 | $43.35K 10-Q · filed 2024-11-07 | $123.30K derived: sum of 2 quarters · filed 2024-11-07 | $338.18K 10-Q · filed 2024-11-07 | -$691.60K derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | $79.94K 10-Q · filed 2024-08-07 | $294.82K 10-Q · filed 2024-08-07 | -$734.95K derived: sum of 3 quarters · filed 2025-02-27 | -$704.05K derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | $214.88K 10-Q · filed 2024-05-08 | -$214.88K 10-Q · filed 2023-05-09 | -$814.89K derived: sum of 2 quarters · filed 2025-02-27 | -$783.99K derived: sum of 3 quarters · filed 2025-02-27 | -$768.35K derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | -$1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$998.87K derived: sum of 2 quarters · filed 2025-02-27 | -$983.23K derived: sum of 3 quarters · filed 2025-02-27 | -$987.48K 10-K · filed 2025-02-27 | $987.48K 10-K · filed 2023-03-14 | |
| 2022-09-30 | $30.90K 10-Q · filed 2023-11-06 | $46.54K derived: sum of 2 quarters · filed 2023-11-06 | $42.29K 10-Q · filed 2023-11-06 | |||
| 2022-06-30 | $15.64K 10-Q · filed 2023-08-08 | $11.39K 10-Q · filed 2023-08-08 | ||||
| 2022-03-31 | $4.25K 10-Q · filed 2023-05-09 | |||||
| 2021-12-31 | -$40.09K 10-K · filed 2024-02-28 | $40.09K 10-K · filed 2023-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |